AMERISAFE (AMSF)
(Delayed Data from NSDQ)
$54.95 USD
+1.14 (2.12%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $54.91 -0.04 (-0.07%) 7:52 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$54.95 USD
+1.14 (2.12%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $54.91 -0.04 (-0.07%) 7:52 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Zacks News
Can Amerisafe (AMSF) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Amerisafe (AMSF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What's in the Offing for CME Group (CME) This Earnings Season?
by Zacks Equity Research
CME Group's first-quarter revenues are likely to have benefited from clearing and transaction fees, market data and information services and other revenues, strong market position and varied derivative product lines.
Aflac (AFL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Aflac's (AFL) first-quarter results are likely to reflect higher adjusted net investment income and cost-curbing efforts, partly offset by weaker sales.
Amerisafe (AMSF) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Amerisafe (AMSF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Amerisafe (AMSF) Up 8% Since Last Earnings Report?
by Zacks Equity Research
Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
What Makes Amerisafe (AMSF) a New Buy Stock
by Zacks Equity Research
Amerisafe (AMSF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Factors Setting the Tone for Guidewire's (GWRE) Q2 Earnings
by Zacks Equity Research
Guidewire's (GWRE) fiscal second-quarter results are likely to reflect gains from robust implementation of cloud-based InsurancePlatform suite of solutions.
AMERISAFE (AMSF) Beats Q4 Earnings Estimates, Hikes Dividend
by Zacks Equity Research
AMERISAFE's (AMSF) fourth-quarter results witness payroll audits and related premium adjustments partly benefiting premiums. However, lower revenues and elevated costs somewhat offset the results.
Analysts Estimate Amerisafe (AMSF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Amerisafe (AMSF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Accident & Health Insurance Stocks to Watch Amid Soft Pricing
by Tanuka De
Higher claims frequency leading to upward pricing pressure coupled with adoption of technology is likely to boost performance of Zacks Accident and Health Insurance industry insurance players like AFL, AMSF and EIG.
Reasons for Betting on Amerisafe (AMSF) to Boost Portfolio
by Zacks Equity Research
Amerisafe's (AMSF) presence in workers' compensation insurance and its disciplined underwriting abilities make the stock an attractive bet.
Amerisafe (AMSF) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Amerisafe (AMSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Unum (UNM) Enters Into $7.1B Reinsurance Deal With Global Atlantic
by Zacks Equity Research
Unum (UNM) inks a deal with Global Atlantic to reinsure its Closed Individual Disability Insurance Block business.
Guidewire (GWRE) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Guidewire's (GWRE) fiscal first-quarter results are likely to reflect gains from the robust implementation of cloud-based InsurancePlatform suite of solutions.
Here's Why Investors Should Bet on Amerisafe (AMSF) Stock Now
by Zacks Equity Research
Amerisafe (AMSF) remains well-poised for growth on the back of its disciplined approach to underwriting and prudent capital management strategies.
Why Is Amerisafe (AMSF) Down 2.4% Since Last Earnings Report?
by Zacks Equity Research
Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Add Hartford Financial (HIG) to Your Portfolio?
by Zacks Equity Research
Backed by its strategic measures and a sturdy capital structure, Hartford Financial (HIG) holds promises to reap benefits for investors.
Aflac (AFL) Rides on U.S. Business Growth, Cost-Control Moves
by Zacks Equity Research
Initiatives to grow its U.S. segment, strong capital position and cost-saving efforts poise Aflac (AFL) for growth.
Amerisafe (AMSF) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Amerisafe (AMSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Amerisafe (AMSF) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of 68.12% and -1.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Amerisafe (AMSF) Q3 Earnings Expected to Decline
by Zacks Equity Research
Amerisafe (AMSF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aflac (AFL) Drops 28% YTD: Will It Make a Comeback Soon?
by Zacks Equity Research
Aflac (AFL) struggles with a weak operating landscape and business inconsistencies in the Japan segment.
Guidewire's (GWRE) InsuranceSuite Adopted by Trillium Mutual
by Zacks Equity Research
Guidewire's (GWRE) InsuranceSuite and other solutions will be implemented by Canada-based agri-business mutual insurer, Trillium Mutual.
The Zacks Analyst Blog Highlights: AFL, UNM, AMSF and EIG
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AFL, UNM, AMSF and EIG
Amerisafe Enters Oversold Territory
by Zacks Equity Research
AMERISAFE has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.